V. B. D. Silva

Oral live attenuated human rotavirus vaccine (Rotarix™) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children.

L. van Doorn, C. Oliveira, A. Linhares, 2012, Memorias do Instituto Oswaldo Cruz.

Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy Brazilian infants Segurança, imunogenicidade e eficácia protetora de duas doses da vacina RIX4414 contendo rotavírus atenuado de origem humana

Eliete da Cunha Araújo, N. Sanchez, A. C. Linhares, 2007 .